| Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” P Moulin, R Dufour, M Averna, M Arca, AB Cefalù, D Noto, L D'Erasmo, ... Atherosclerosis 275, 265-272, 2018 | 212 | 2018 |
| Clinical and biochemical features of different molecular etiologies of familial chylomicronemia RA Hegele, AJ Berberich, MR Ban, J Wang, A Digenio, VJ Alexander, ... Journal of clinical lipidology 12 (4), 920-927. e4, 2018 | 131 | 2018 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 100 | 2022 |
| Bone damage in type 2 diabetes mellitus V Carnevale, E Romagnoli, L D'Erasmo, E D'Erasmo Nutrition, Metabolism and Cardiovascular Diseases 24 (11), 1151-1157, 2014 | 89 | 2014 |
| Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ... Advances in therapy 34, 1200-1210, 2017 | 80 | 2017 |
| Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy A Di Costanzo, F Belardinilli, D Bailetti, M Sponziello, L D’Erasmo, ... Scientific reports 8 (1), 3702, 2018 | 78 | 2018 |
| High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects R Scicali, P Giral, L d'Erasmo, P Cluzel, A Redheuil, A Di Pino, ... Diabetes/metabolism research and reviews 37 (2), e3367, 2021 | 64 | 2021 |
| Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy G Mitacchione, M Schiavone, A Curnis, M Arca, S Antinori, A Gasperetti, ... Journal of clinical lipidology 15 (1), 68-78, 2021 | 61 | 2021 |
| Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies A Cesaro, A Schiavo, E Moscarella, S Coletta, M Conte, F Gragnano, ... Journal of Cardiovascular Medicine 22 (3), 151-161, 2021 | 59 | 2021 |
| Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis D Pastori, A Pani, A Di Rocco, D Menichelli, G Gazzaniga, A Farcomeni, ... British Journal of Clinical Pharmacology 88 (2), 441-451, 2022 | 57 | 2022 |
| Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes L D’Erasmo, A Di Costanzo, F Cassandra, I Minicocci, L Polito, A Montali, ... Arteriosclerosis, Thrombosis, and Vascular Biology 39 (12), 2531-2541, 2019 | 53 | 2019 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| Autosomal recessive hypercholesterolemia: long-term cardiovascular outcomes L D’Erasmo, I Minicocci, A Nicolucci, P Pintus, JE Roeters Van Lennep, ... Journal of the American College of Cardiology 71 (3), 279-288, 2018 | 50 | 2018 |
| Association of hypertriglyceridemia with all‐cause mortality and atherosclerotic cardiovascular events in a low‐risk Italian Population: the TG‐REAL retrospective cohort analysis M Arca, C Veronesi, L D’Erasmo, C Borghi, F Colivicchi, GM De Ferrari, ... Journal of the American Heart Association 9 (19), e015801, 2020 | 49 | 2020 |
| Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia A Di Costanzo, E Di Leo, D Noto, AB Cefalù, I Minicocci, L Polito, ... Journal of Clinical Lipidology 11 (5), 1234-1242, 2017 | 49 | 2017 |
| Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically-versus genetically-driven excess fat hepatic storage A Di Costanzo, L D'Erasmo, L Polimeni, F Baratta, P Coletta, M Di Martino, ... Atherosclerosis 257, 232-239, 2017 | 47 | 2017 |
| Familial combined hypolipidemia: angiopoietin-like protein-3 deficiency M Arca, L D’Erasmo, I Minicocci Current opinion in lipidology 31 (2), 41-48, 2020 | 40 | 2020 |
| Nonalcoholic fatty liver disease (NAFLD), but not its susceptibility gene variants, influences the decrease of kidney function in overweight/obese children A Di Costanzo, L Pacifico, L D’Erasmo, L Polito, M Di Martino, FM Perla, ... International journal of molecular sciences 20 (18), 4444, 2019 | 37 | 2019 |
| Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways V Cammisotto, F Baratta, V Castellani, S Bartimoccia, C Nocella, ... International Journal of Molecular Sciences 22 (13), 7193, 2021 | 36 | 2021 |
| Metabolomic signature of angiopoietin-like protein 3 deficiency in fasting and postprandial state E Tikkanen, I Minicocci, J Hällfors, A Di Costanzo, L D’Erasmo, ... Arteriosclerosis, Thrombosis, and Vascular Biology 39 (4), 665-674, 2019 | 35 | 2019 |
